FDA records indicate that there are no current recalls for this drug.
Are you a medical professional?
Trending Topics
Cutis Compositum Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
Warnings and Precautions
If new symptoms occur, or if redness, pain or swelling at the puncture site persists, the patient should be carefully re-evaluated because these could be signs of a more serious condition.
Pregnancy Category C. Animal reproduction studies have not been conducted with this drug. It is also not known whether this drug can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. This drug should be given to a pregnant woman only if clearly needed.
To report SUSPECTED ADVERSE REACTIONS, contact Heel Inc. at 1.800.920.9203 or info@heelusa.com or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
Cutis compositum® Injection Solution is indicated for stimulation of the defense system and for influence upon the homotoxic terrain in chronic skin disorders.
Cutis compositum® Injection Solution is classified as a homeopathic combination drug.
Botanical ingredients:
Aesculus hippocastanum (horse chestnut)
Lappa major (great burdock)
Galium aparine (cleavers/goose grass)
Ignatia amara (St. Ignatius’ bean)
Ledum palustre (marsh tea)
Thuja occidentalis (white cedar)
Urtica urens (small stinging nettle)
Mineral ingredients:
Calcarea fluorica (calcium fluoride)
Cortisone aceticum (cortisone)
Formicum acidum (formic acid)
Fumaricum acidum (fumaric acid)
Ichthyolum (ammonium bituminosulfonate)
α-Ketoglutaricum acidum (α-ketoglutaric acid)
Mercurius solubilis (Hahnemann’s soluble mercury)
Natrum oxalaceticum (disodium ethyloxaloacetate)
Phosphoricum acidum (phosphoric acid)
Selenium metallicum (selenium)
Sulphur (sulfur)
Thallium sulphuricum (thallium sulfate)
Animal-derived ingredients
Cutis suis (porcine skin)
Funiculus umbilicalis suis (porcine umbilical cord)
Glandula suprarenalis suis (porcine adrenal gland)
Hepar suis (porcine liver)
Placenta suis (porcine placenta)
Splen suis (porcine spleen)
History
There is currently no drug history available for this drug.
Other Information
Injection Solution Ingredient Information: Ledum palustre 4X, Urtica urens 4X, Aesculus hippocastanum 6X, Galium aparine 6X, Ignatia amara 6X, Lappa major 6X, Phosphoricum acidum 6X, Cutis suis 8X, Thuja occidentalis 8X, Fumaricum acidum 10X, Funiculus umbilicalis suis 10X, Glandula suprarenalis suis 10X, Hepar suis 10X, α-Ketoglutaricum acidum 10X, Natrum oxalaceticum 10X, Placeta suis 10X, Selenium metallicum 10X, Splen suis 10X, Sulphur 10X, Calcarea fluorica 13X, Mercurius solubilis 13X, Thallium sulphuricum 13X, Cortisone aceticum 28X, Ichthyolum 28X, Formicum acidum 198X 22 mcl each. Inactive ingredient: Sterile isotonic sodium chloride solution.
Sources
Cutis Compositum Manufacturers
-
Heel Inc
Cutis Compositum | Heel Inc
The dosage schedules listed below can be used as a general guide for the administration of Cutis compositum® Injection Solution. Cutis compositum® Injection Solution shows individual differences in clinical response. Therefore, the dosage for each patient should be individualized according to the patient’s response to therapy.
Adults and children 7 years and older: 1 ampule daily for acute disorders, or 1 ampule 1 to 3 times perweek. Children ages 2 to 6 years receive: ½ the adult dosage.
Discard unused solution.
Login To Your Free Account